Ark Biosciences
China - ShanghaiBiotechnology
Focus: Ark Biosciences is a Shanghai-based biotech startup founded in 2021 focused on respiratory virus therapeutics. The company is early-stage with a minimal pipeline and limited scale.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Ark Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Ark Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AK0406
Healthy ParticipantsClinical Trials (1)
NCT07432698A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants
Phase 1Help build intelligence for Ark Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.